FDA event 83136 · Recall Observatory

drug · product 1 of 76

Oxytocin 60 units/1000 mL Lactated Ringers Intravenous Solution, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1744-2019

Recall number: D-1744-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: 820 60 units/bag

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 2 of 76

Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1745-2019

Recall number: D-1745-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 3 of 76

Adcetris 96 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1746-2019

Recall number: D-1746-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 4 of 76

ADO-TRASTUZUMAB 210 MG/250 ml NS; ADO-TRASTUZUMAB E 213 MG / 250 ML NS; ADO-TRASTUZUMAB 242 MG/250 ml NS; ADO-TRASTUZUMAB EMT 168 mg / 250 ml NS; ADO-TRASTUZUMAB E 160 MG / 250 ML NS ADO-TRASTUZUMAB 150 mg / 250 ml NS; ADO-TRASTUZUMAB EMT 301 mg / 250 ml NS; ADO-TRASTUZUMAB EMTANSINE 230mg/250ml NS IV Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1747-2019

Recall number: D-1747-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 5 of 76

ALIMTA 785 mg QS 100 ml 0.9% NACL IVPB; ALIMTA 1000 mg QS 100 ml 0.9% NACL IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1748-2019

Recall number: D-1748-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 6 of 76

ATEZOLIZUMAB 1200 MG / 250 ML 0.9% NACL, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1749-2019

Recall number: D-1749-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 7 of 76

AVASTIN 630 MG / 100 ML 0.9% NACL IVPB; AVASTIN 2.5 mg/ 0.1ML Syringe; AVASTIN 587.5 MG/100 ML 0.9% NACL IVPB; AVASTIN 350 MG/100 ML 0.9% NACL IVPB; AVASTIN 325 MG / 100 ML 0.9% NACL IVPB; AVASTIN 3.75 mg/ 0.15 ML Syringe; AVASTIN 416 MG / 100 ML 0.9% NACL IVPB; AVASTIN 360 MG/100 ML 0.9% NACL IVPB; AVASTIN 250 MG / 100 ML 0.9% NACL IVPB; AVASTIN 693.125 MG/100 ML 0.9% NACL IVPB; AVASTIN 1020 MG/100 ML NS IVPB; AVASTIN 811.875 MG/100 ML 0.9% NACL IVPB; AVASTIN 1006.25 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1750-2019

Recall number: D-1750-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 8 of 76

AZACITIDINE 125 MG / 5 ML SUB-Q SYRINGE; AZACITIDINE 75 MG (3 ML) SYRINGE, AZACITIDINE 135 MG / 5.4 ML SUB-Q SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1751-2019

Recall number: D-1751-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 9 of 76

BEVACIZUMAB 784 MG / 100 ML NS IVPB; BEVACIZUMAB 350 MG/100 ml NS IVPB; BEVACIZUMAB 425 MG/ 100 ml NS IVPB; BEVACIZUMAB 420 MG/100 ml 0.9% NACL IVPB; BEVACIZUMAB 556 mg/100 ml NS IVPB BEVACIZUMAB 330 MG / 100 ML NS IVPB; BEVACIZUMAB 790 MG / 100 ML NS IVPB; BEVACIZUMAB 470 MG / 100 ML NS IVPB; BEVACIZUMAB 758 MG / 100 ML NS IVPB; BEVACIZUMAB 690 MG / 100 ML NS IVPB BEVACIZUMAB 599 MG/100 ml NS IVPB; BEVACIZUMAB 1113 MG / 100 ML NS IVPB; BEVACIZUMAB 660 MG /100 ml NS IVPB; BEVACIZUMAB 590 MG / 100 ML NS IVPB; BEVACIZUMAB 620 MG / 100 ML NS IVPB BEVACIZUMAB 800 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1752-2019

Recall number: D-1752-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

all lots within expiry

Distribution pattern

NY only

drug · product 10 of 76

BLEOMYCIN 18 UNITS / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1753-2019

Recall number: D-1753-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 11 of 76

BORTEZOMIB 2.5 mg / 1 ML SQ SYRINGE; BORTEZOMIB 2.88 MG / 1.15 ML SQ SYRINGE; BORTEZOMIB 2.31 MG / 0.92 ml SQ SYRINGE; BORTEZOMIB 2.7 mg / 1.08 ML SQ SYRINGE; BORTEZOMIB 1.45 mg / 0.58 ml SQ SYRINGE; BORTEZOMIB 2.25 mg (0.9 ML) SQ SYRINGE; BORTEZOMIB 1.98 mg / 0.79 ml SQ SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1754-2019

Recall number: D-1754-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 12 of 76

CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1755-2019

Recall number: D-1755-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 13 of 76

CARBOPLATIN 174 MG / 250ml NS IVPB; CARBOPLATIN 240 MG / 250 ML NS IVPB; CARBOPLATIN 750 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 895 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 235 MG / 250ml NS IVPB CARBOPLATIN 716 MG / 250 ML D5W IVPB; CARBOPLATIN 400 MG / 500 ML NS IVPB; CARBOPLATIN 500 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 575 MG / 500 ML NS IVPB; CARBOPLATIN 307 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 766 MG / 500 ML NS IVPB; CARBOPLATIN 684 / 250 ML NACL 0.9% IVPB; CARBOPLATIN 260 MG / 100 ML D5W IVPB CARBOPLATIN 360 MG /100 ML NACL 0.9% IVPB; CARBOPLATIN 274 MG / 250 ML D5W IVPB; CARBOPLATIN 240 MG / 100 ML D5W IVPB; CARBOPLATIN 750 MG / 250 ML NS IVPB; CARBOPLATIN 260 MG / 250 ML NS IVPB; CARBOPLATIN 460 MG / 250 ML NS IVPB; CARBOPLATIN 175 MG / 250 ML NS IVPB; CARBOPLATIN 229.4 MG / 500 ML NS IVPB CARBOPLATIN 780 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 140 MG / 250 ML NS IVPB; CARBOPLATIN 408 MG / 500 ML NS IVPB CARBOPLATIN 847 MG / 250 ML D5W IVPB; CARBOPLATIN 560 MG / 250 ML D5W IVPB; CARBOPLATIN 180 MG / 250 ML NS IVPB; CARBOPLATIN 200 MG / 250 ML D5W IVPB; CARBOPLATIN 238 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1756-2019

Recall number: D-1756-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 14 of 76

CARFILZOMIB 65 MG IN 50 ML D5W IVPB; CARFILZOMIB 75 MG IN 50 ML D5W IVPB; CARFILZOMIB 50 MG IN 50 ML D5W IVPB; CARFILZOMIB 45 MG IN 50 ML D5W IVPB; CARFILZOMIB 46.2 MG IN 50 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1757-2019

Recall number: D-1757-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 15 of 76

CETUXIMAB 335 MG / 167.5 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1758-2019

Recall number: D-1758-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 16 of 76

Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.9% NACL; Cisplatin 44 MG QS 500 ml NS IVPB; Cisplatin 40 MG / 500 ml 0.9% NACL; Cisplatin 36 MG / 500 ML NS IVPB; Cisplatin 73 MG QS 500 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 70 MG / 500 ml NS WITH Magnesium 1 G and Mannitol 12.5 G; Cisplatin 60 MG /250 ml 0.9% NACL Cisplatin 47 MG /250 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 150 MG / 250 ml 0.9% NACL; Cisplatin 115 MG /250 ml NS IVPB; Cisplatin 80 MG QS 500 ml NS IVPB WITH Mannitol 12.5 G; Cisplatin 120 MG / 500 ML NS IVPB Cisplatin 157 MG /250 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 43 MG QS 1000 ml 0.9% NACL WITH Mannitol 12.5 G, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1759-2019

Recall number: D-1759-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 17 of 76

Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.9% NACL; Cisplatin 44 MG QS 500 ml NS IVPB; Cisplatin 40 MG / 500 ml 0.9% NACL; Cisplatin 36 MG / 500 ML NS IVPB; Cisplatin 73 MG QS 500 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 70 MG / 500 ml NS WITH Magnesium 1 G and Mannitol 12.5 G; Cisplatin 60 MG /250 ml 0.9% NACL Cisplatin 47 MG /250 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 150 MG / 250 ml 0.9% NACL; Cisplatin 115 MG /250 ml NS IVPB; Cisplatin 80 MG QS 500 ml NS IVPB WITH Mannitol 12.5 G; Cisplatin 120 MG / 500 ML NS IVPB Cisplatin 157 MG /250 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 43 MG QS 1000 ml 0.9% NACL WITH Mannitol 12.5 G, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1760-2019

Recall number: D-1760-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 18 of 76

Cyclophosphamide 840 MG / 250 ML NS IVPB; Cyclophosphamide 1112 MG / 250 ML NS IVPB; Cyclophosphamide 1248 MG / 50 ML NS IVPB; Cyclophosphamide 1125 MG / 100 ML NS IVPB; Cyclophosphamide 1000 MG / 500 ML NS IVPB; Cyclophosphamide 1400 MG / 100 ML NS IVPB Cyclophosphamide 1056 MG / 250 ML NS IVPB; Cyclophosphamide 980 MG / 500 ML NS IVPB; Cyclophosphamide 580 mg / 500 ML NS IVPB; Cyclophosphamide 880 MG / 500 ML NS IVPB; Cyclophosphamide 501 MG / 250 ML NS IVPB; Cyclophosphamide 1163 MG / 50 ML NS IVPB Cyclophosphamide 1100 MG / 500 ML NS IVPB; Cyclophosphamide 1152 MG / 250 ML NS IVPB; Cyclophosphamide 1116 MG / 250 ML NS IVPB Cyclophosphamide 894 MG / 250 ML NS IVPB; Cyclophosphamide 1210 MG / 500 ML NS IVPB; Cyclophosphamide 1010 MG/ 500 ML NS IVPB Cyclophosphamide 1030 MG / 500 ML NS IVPB; Cyclophosphamide 500 MG / 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1761-2019

Recall number: D-1761-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 19 of 76

Cytarabine 128 MG/250 ML D5W IVPB; Cytarabine 20 MG / 1 ML SQ SYRINGE Cytarabine 70 MG QS 6 ML PF NS SYRINGE; Cytarabine 100 MG QS 3 ML PF NS SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1762-2019

Recall number: D-1762-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 20 of 76

DACARBAZINE 680 MG in 250 ml NS; DACARBAZINE 675 MG in 250 ml NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1763-2019

Recall number: D-1763-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 21 of 76

DARATUMUMAB 904 MG QS 500 ML NS IVPB; DARATUMUMAB 668 MG QS 1000 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1764-2019

Recall number: D-1764-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 22 of 76

DARZALEX 1008 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1765-2019

Recall number: D-1765-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 23 of 76

DECITABINE 40 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1766-2019

Recall number: D-1766-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 24 of 76

DEXAMETHASONE 10 MG / 50 ML NS IVPB; DEXAMETHASONE 5 MG / 50 ML NS; DEXAMETHASONE 5 MG / 50 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1767-2019

Recall number: D-1767-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 25 of 76

DIPHENHYDRAMINE 25 MG/50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1768-2019

Recall number: D-1768-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 26 of 76

DOCETAXEL 60 MG / 250 ml D5W IVPB; DOCETAXEL 71 MG/ 250 ML NS IVPB; DOCETAXEL 155 MG/ 250 ml NS IVPB; DOCETAXEL 110 mg / 250 ml NS IVPB; DOCETAXEL 150 MG / 250 ml NS IVPB; DOCETAXEL 137 mg / 250 ml 0.9% NACL IVPB; DOCETAXEL 130 MG/ 250 ml NS IVPB; DOCETAXEL 140 MG/ 250 ml NS IVPB; DOCETAXEL 144 MG/ 250 ML NS IVPB; DOCETAXEL 117 MG/ 250 ML NS IVPB; DOCETAXEL 30 mg / 250 ml D5W IVPB; DOCETAXEL 125 MG/ 250 ml NS IVPB; DOCETAXEL 135 MG / 250 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1769-2019

Recall number: D-1769-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 27 of 76

Doxorubicin 110 MG / 55 ML IVP SYRINGE; Doxorubicin 56 MG / 28 ML IVP SYRINGE; Doxorubicin 75 MG / 37.5 ML IVP SYRINGE; Doxorubicin 125 MG / 62.5 ML SYRINGE IVP; Doxorubicin 93 MG / 46.5 ML IV SYRINGE; Doxorubicin 112 MG / 56 ML IVP SYRINGE; Doxorubicin 50 MG / 25 ML IVP SYRINGE; Doxorubicin 120 MG / 60 ML IVP SYRINGE; Doxorubicin 106 MG / 53 ML IVP SYRINGE; Doxorubicin 90 MG / 45 ML IVP SYRINGE; Doxorubicin 14 MG/500 ML NS IV WITH Vincristine 0.7 MG and Etoposide 70 MG; Doxorubicin 100 MG / 50 ML IVP SYRINGE; Doxorubicin 16 MG/1000 ML NS IV WITH Vincristine 0.6 MG and Etoposide 78 MG; Doxorubicin 45 MG / 22.5 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1770-2019

Recall number: D-1770-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 28 of 76

Doxorubicin Liposomal 71 MG / 250 ML D5W IVPB; Doxorubicin Liposomal 66 MG/250 ML D5W, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233 Doxorubicin 16 MG/1000 ML NS IV WITH Vincristine 0.6 MG and Etoposide 78 MG Doxorubicin 16 MG/1000 ML NS IV WITH Vincristine 0.6 MG and Etoposide 78 MG Duplicate Doxorubicin 45 MG / 22.5 ML IVP SYRINGE

D-1771-2019

Recall number: D-1771-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 29 of 76

Durvalumab 651 mg/ 250 ml NS IVPB; Durvalumab 650 mg/ 250 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1772-2019

Recall number: D-1772-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 30 of 76

ENTYVIO 300 MG /250 ML 0.9% NACL, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1773-2019

Recall number: D-1773-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 31 of 76

ERBITUX 770 MG/ 385 ML IVPB; ERBITUX 440 MG/ 220 ml IVPB; ERBITUX 850 MG/ 425 ml IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1774-2019

Recall number: D-1774-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 32 of 76

ERIBULIN 1.12 MG / 100 ML NS IVPB; ERIBULIN 1.87 MG / 100 ML NS IVPB; ERIBULIN 1.89 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1775-2019

Recall number: D-1775-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 33 of 76

Etoposide 184 MG / 500 ml NS IVPB; Etoposide 176 MG/ 500 ml 0.9% NACL IVPB; Etoposide 170 MG / 500 ml 0.9% NACL IVPB; Etoposide 152 MG / 500 ml 0.9% NACL IVPB; Etoposide 275 MG / 500 ml NS IVPB; Etoposide 270 MG / 500 ml NS IVPB; Etoposide 90 MG / 500 ml NS IVPB; Etoposide 160 MG / 500 ml NS IVPB; Etoposide 178 MG/ 500 ml 0.9% NACL IVPB; Etoposide 214 MG / 500 ml NS IVPB; Etoposide 290 MG / 500 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1776-2019

Recall number: D-1776-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 34 of 76

Fluorouracil 560 MG / 11.2 ML IVP; Fluorouracil 3340 MG QS 92 ML 0.9% NACL; Fluorouracil 3920 MG QS 92 ML 0.9% NACL; Fluorouracil 3760 mg QS 100 ml NS CASS; Fluorouracil 4000 MG QS 92 ml 0.9% NACL; Fluorouracil 3140 MG QS 240 ML NS PUMP; Fluorouracil 2400 MG QS 96 ML 0.9% NACL Fluorouracil 5000 MG QS 101 ml 0.9% NACL; Fluorouracil 750 MG / 15 ML IVP Fluorouracil 4500 mg QS 100 ml NS CASS; Fluorouracil 4100 mg QS 100 ml NS CASS; Fluorouracil 690 mg / 13.8 ml IVP; Fluorouracil 2400 MG QS 96 ML NS IV; Fluorouracil 812 MG/16.24 ML IVP; Fluorouracil 4872 MG QS 240 ML NS PUMP; Fluorouracil 4200 mg QS 100 ml NS CASS; Fluorouracil 1110 MG QS 96 ml NS IVPB; Fluorouracil 370 MG/ 50 ML NS; Fluorouracil 620 MG/ 12.4 ML SYRINGE IVP; Fluorouracil 3160 MG QS 92 ML 0.9% NACL; Fluorouracil 1050 mg QS 92 ml NS IVPB; Fluorouracil 370 MG /100 ML NS IVPB; Fluorouracil 4080 MG QS 1000 ML NS IVPB; Fluorouracil 5 MG / 0.1 ML SYRINGE; Fluorouracil 5040 MG QS 101 ml NS CADD; Fluorouracil 4224 MG QS 100 ml NS CASS; Fluorouracil 700 MG / 14 ML IVP; Fluorouracil 3550 mg QS 92 ML 0.9% NACL IV; Fluorouracil 760 MG / 15.2 ML IVP; Fluorouracil 4560 MG QS 240 ML NS PUMP; Fluorouracil 796 MG / 15.92 MLIVP Fluorouracil 4776 MG QS 240 ML NS PUMP; Fluorouracil 930 MG QS 240 ML NS PUMP; Fluorouracil 730 MG / 14.6 ML IVP SYR; Fluorouracil 4400 MG QS 100 ml NS CADD; Fluorouracil 2430 MG QS 96 ml 0.9% NACL; Fluorouracil 4728 MG QS 100 ml NS CASS; Fluorouracil 3550 MG QS 92 ML 0.9% NACL Fluorouracil 588 MG / 11.76 ML IVP; Fluorouracil 3528 MG QS 240 ML NS PUMP; Fluorouracil 2520 mg QS 96 ml NS IVPB; Fluorouracil 790 MG / 15.8 ml IVP; Fluorouracil 4750 mg QS 97 ml 0.9% NACL IV; Fluorouracil 2660 MG QS 96 ml NS IVPB; Fluorouracil 720 MG/ 14.4 ML IVP; Fluorouracil 4370 mg QS 92 ml 0.9% NACL IV; Fluorouracil 3280 MG QS 92 ML 0.9% NACL; Fluorouracil 780 MG / 15.6 ML IVP; Fluorouracil 4660 MG QS 97 ml 0.9% NACL Fluorouracil 3620 MG QS 100 ml NS CASS; Fluorouracil 2370 MG QS 92 ML 0.9% NACL; Fluorouracil 800 MG / 16 ML IVP; Fluorouracil 4800 MG QS 101 ml NS CADD; Fluorouracil 4000 mg QS 92 ML 0.9% NACL IV; Fluorouracil 2480 MG QS 96 ML 0.9% NACL; Fluorouracil 688 MG / 13.76 ml IVP Fluorouracil 4128 MG QS 1000 ML D5W IVPB; Fluorouracil 6000 MG QS 250 ml NS CASS; Fluorouracil 672 MG / 13.44 ML IVP; Fluorouracil 4032 MG / 1000 ML D5W IVPB; Fluorouracil 894 MG / 17.88 ml IVP; Fluorouracil 400 MG / 50 ML NS IVPB; Fluorouracil 840 MG / 16.8 ml IVP; Fluorouracil 590 MG/ 11.8 ML IVP, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1777-2019

Recall number: D-1777-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 35 of 76

FOSAPREPITANT 150 mg/150 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1778-2019

Recall number: D-1778-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lot within expiry

Distribution pattern

NY only

drug · product 36 of 76

Fluorouracil 560 MG / 11.2 ML IVP Fluorouracil 3340 MG QS 92 ML 0.9% NACL Fluorouracil 3920 MG QS 92 ML 0.9% NACL Fluorouracil 3760 mg QS 100 ml NS CASS Fluorouracil 4000 MG QS 92 ml 0.9% NACL Fluorouracil 3140 MG QS 240 ML NS PUMP Fluorouracil 2400 MG QS 96 ML 0.9% NACL Fluorouracil 5000 MG QS 101 ml 0.9% NACL Fluorouracil 750 MG / 15 ML IVP Fluorouracil 4500 mg QS 100 ml NS CASS Fluorouracil 4100 mg QS 100 ml NS CASS Fluorouracil 690 mg / 13.8 ml IVP Fluorouracil 2400 MG QS 96 ML NS IV Fluorouracil 812 MG/16.24 ML IVP Fluorouracil 4872 MG QS 240 ML NS PUMP Fluorouracil 4200 mg QS 100 ml NS CASS Fluorouracil 1110 MG QS 96 ml NS IVPB Fluorouracil 370 MG/ 50 ML NS Fluorouracil 620 MG/ 12.4 ML SYRINGE IVP Fluorouracil 3160 MG QS 92 ML 0.9% NACL Fluorouracil 1050 mg QS 92 ml NS IVPB Fluorouracil 370 MG /100 ML NS IVPB Fluorouracil 4080 MG QS 1000 ML NS IVPB Fluorouracil 5 MG / 0.1 ML SYRINGE Fluorouracil 5040 MG QS 101 ml NS CADD Fluorouracil 4224 MG QS 100 ml NS CASS Fluorouracil 700 MG / 14 ML IVP Fluorouracil 3550 mg QS 92 ML 0.9% NACL IV Fluorouracil 760 MG / 15.2 ML IVP Fluorouracil 4560 MG QS 240 ML NS PUMP Fluorouracil 796 MG / 15.92 MLIVP Fluorouracil 4776 MG QS 240 ML NS PUMP Fluorouracil 930 MG QS 240 ML NS PUMP Fluorouracil 730 MG / 14.6 ML IVP SYR Fluorouracil 4400 MG QS 100 ml NS CADD Fluorouracil 2430 MG QS 96 ml 0.9% NACL Fluorouracil 4728 MG QS 100 ml NS CASS Fluorouracil 3550 MG QS 92 ML 0.9% NACL Fluorouracil 588 MG / 11.76 ML IVP Fluorouracil 3528 MG QS 240 ML NS PUMP Fluorouracil 2520 mg QS 96 ml NS IVPB Fluorouracil 790 MG / 15.8 ml IVP Fluorouracil 4750 mg QS 97 ml 0.9% NACL IV Fluorouracil 2660 MG QS 96 ml NS IVPB Fluorouracil 720 MG/ 14.4 ML IVP Fluorouracil 4370 mg QS 92 ml 0.9% NACL IV Fluorouracil 3280 MG QS 92 ML 0.9% NACL Fluorouracil 780 MG / 15.6 ML IVP Fluorouracil 4660 MG QS 97 ml 0.9% NACL Fluorouracil 3620 MG QS 100 ml NS CASS Fluorouracil 2370 MG QS 92 ML 0.9% NACL Fluorouracil 800 MG / 16 ML IVP Fluorouracil 4800 MG QS 101 ml NS CADD Fluorouracil 4000 mg QS 92 ML 0.9% NACL IV Fluorouracil 2480 MG QS 96 ML 0.9% NACL Fluorouracil 688 MG / 13.76 ml IVP Fluorouracil 4128 MG QS 1000 ML D5W IVPB Fluorouracil 6000 MG QS 250 ml NS CASS Fluorouracil 672 MG / 13.44 ML IVP Fluorouracil 4032 MG / 1000 ML D5W IVPB Fluorouracil 894 MG / 17.88 ml IVP Fluorouracil 400 MG / 50 ML NS IVPB Fluorouracil 840 MG / 16.8 ml IVP Fluorouracil 590 MG/ 11.8 ML IVP

D-1779-2019

Recall number: D-1779-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 37 of 76

GAZYVA 100 MG IN 250 ML NS IVPB; GAZYVA 900 MG IN 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1780-2019

Recall number: D-1780-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 38 of 76

Gemcitabine 1910 MG / 250 ML NS IVPB; Gemcitabine 1140 MG / 250 ML NS 0.9% IVPB; Gemcitabine 1290 MG /250 ML NS IVPB; Gemcitabine 460 MG / 250 ML NS IVPB; Gemcitabine 880 MG / 250 ML NS IVPB; Gemcitabine 810 MG / 250 ML NS IVPB; Gemcitabine 820 MG / 250 ML NS IVPB; Gemcitabine 1748 MG / 250 ML NS IVPB; Gemcitabine 890 MG /250 ML NS IVPB Gemcitabine 2000 MG /250 ML 0.9% NACL IVPB; Gemcitabine 660 MG / 250 ML NS IVPB; Gemcitabine 1880 MG /250 ML NS IVPB; Gemcitabine 1180 MG / 250 ML NS IVPB; Gemcitabine 1400 MG / 250 ML NS IVPB Gemcitabine 1300 MG / 250 ML NS IVPB; Gemcitabine 1406 MG /250 ML NS IVPB; Gemcitabine 1672 MG / 250 ML NS IVPB; Gemcitabine 2050 MG / 250 ML NS IVPB; Gemcitabine 1260 MG / 250 ML NS IVPB; Gemcitabine 1710 MG / 250 ML NS IVPB; Gemcitabine 1320 MG / 250 ML NS IVPB; Gemcitabine 1200 MG /250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1781-2019

Recall number: D-1781-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 39 of 76

GRANISETRON 1000 MCG / 50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1782-2019

Recall number: D-1782-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 40 of 76

HERCEPTIN 400 MG / 250 ML NS IVPB; HERCEPTIN 340 MG /250 ml 0.9% NACL IVPB; HERCEPTIN 553 MG / 250 ml NS IVPB; HERCEPTIN 305 MG / 250 ml NS IVPB; HERCEPTIN 526 MG / 250 ML NS IVPB; HERCEPTIN 162 MG / 250 ML NS IVPB; HERCEPTIN 354 MG/ 250 ml 0.9% NACL IVPB; HERCEPTIN 440 MG / 250 ML NS IVPB; HERCEPTIN 650 MG / 250 ML NS IVPB; HERCEPTIN 472 MG / 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1783-2019

Recall number: D-1783-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 41 of 76

IFOSFAMIDE 9200 MG / 1 L NS IVPB WITH MESNA 9200 MG, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1784-2019

Recall number: D-1784-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 42 of 76

InFLIXimab 300 mg / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1785-2019

Recall number: D-1785-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 43 of 76

INJECTAFER 720 MG in 100 ml NS IVPB; INJECTAFER 210 MG in 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1786-2019

Recall number: D-1786-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 44 of 76

IRINOTECAN 250 MG /500 ml D5W IVPB; IRINOTECAN 110 MG /250 ML D5W IVPB; IIRINOTECAN 250 MG/250 ML NS IVPB; IRINOTECAN 315 MG / 250 ML NS IVPB; IRINOTECAN 155 MG / 500 ml D5W IVPB; IRINOTECAN 75 MG / 250 ML NS IVPB; IRINOTECAN 140 MG / 250 ML NS IVPB; IRINOTECAN 317 MG /500 ML D5W IVPB; IRINOTECAN 135 mg / 500 ml D5W IVPB; IRINOTECAN 265 MG / 500 ML D5W IVPB; IRINOTECAN 140 MG / 500 ml D5W IVPB; IRINOTECAN 195 mg / 500 ml D5W IVPB; IRINOTECAN 245 mg / 500 ml D5W IVPB; IRINOTECAN 130 MG / 500 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1787-2019

Recall number: D-1787-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 45 of 76

IRON SUCROSE 200 mg / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1788-2019

Recall number: D-1788-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 46 of 76

LEUCOVORIN 560 MG / 250 ML NS IVPB; LEUCOVORIN 830 MG / 250 ml NS IVPB; LEUCOVORIN 300 MG / 50 ml D5W IVPB; LEUCOVORIN 840 MG / 250 ml NS IVPB; LEUCOVORIN 750 MG / 250 ml NS IVPB; LEUCOVORIN 690 MG / 250 ml NS IVPB; LEUCOVORIN 314 mg / 50 ml NS IVPB; LEUCOVORIN 620 MG / 250 ml D5W IVPB; LEUCOVORIN 420 MG / 50 ML D5W IVPB; LEUCOVORIN 700 MG / 250 ml D5W IVPB; LEUCOVORIN 592 mg / 250 ml D5W IVPB; LEUCOVORIN 760 mg / 250 ml D5W IVPB; LEUCOVORIN 796 MG / 250 ml D5W IVPB; LEUCOVORIN 730 MG / 250 ml D5W IVPB; LEUCOVORIN 324 mg / 50 ml NS IVPB; LEUCOVORIN 590 MG / 250 ml D5W IVPB; LEUCOVORIN 336 MG / 50 ml NS IVPB; LEUCOVORIN 398 MG/ 250 ml D5W IVPB; LEUCOVORIN 354 MG / 50 ml NS IVPB; LEUCOVORIN 720 MG / 250 ml D5W IVPB; LEUC; VORIN 328 mg / 50 ml NS IVPB; LEUCOVORIN 776 MG / 250 ml D5W IVPB; LEUCOVORIN 339 MG / 250 ml D5W IVPB; LEUCOVORIN 800 mg / 250 ml D5W IVPB; LEUCOVORIN 330 MG / 50 ml D5W IVPB; LEUCOVORIN 330 MG / 50 ml NS IVPB; LEUCOVORIN 688 MG in 250 ML D5W IVPB; LEUCOVORIN 350 MG / 250 ml NS IVPB; LEUCOVORIN 672 MG / 250 ml D5W IVPB; LEUCOVORIN 588 mg / 250 ml D5W IVPB; LEUCOVORIN 812 MG / 250 ML D5W IVPB; LEUCOVORIN 300 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1789-2019

Recall number: D-1789-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 47 of 76

METHOTREXATE 25 MG / 1 ML IM SYR; METHOTREXATE 12 mg QS 5 ml PF 0.9% NACL; METHOTREXATE 98 MG / 3.92 ML IM SYR; METHOTREXATE 55 MG / 2.2 ML IVP; METHOTREXATE 59.5 MG / 2.38 ML IVP; METHOTREXATE 12 mg QS 6 ml 0.9% NACL; METHOTREXATE 150 MG / 50 ML NS IVPB; METHOTREXATE 112.5 MG/ 4.5 ML IM SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1790-2019

Recall number: D-1790-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 48 of 76

METHYLPREDNISOLONE 10 MG / 0.16 ML IVP, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1791-2019

Recall number: D-1791-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 49 of 76

MITOMYCIN 10 MG /20 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1792-2019

Recall number: D-1792-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 50 of 76

NIVOLUMAB 480 MG / 100 ML NS IVPB; NIVOLUMAB 200 mg / 100 ML NS IVPB; NIVOLUMAB 165 mg / 100 ML NS IVPB; NIVOLUMAB 240 mg / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1793-2019

Recall number: D-1793-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 51 of 76

ONDANSETRON 8 MG / 50 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1794-2019

Recall number: D-1794-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 52 of 76

OPDIVO 200 mg /100 ML NS VPB; OPDIVO 480 mg/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1795-2019

Recall number: D-1795-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 53 of 76

ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1796-2019

Recall number: D-1796-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 54 of 76

OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALIPLATIN 130 MG / 250 ML D5W IVPB; OXALIPLATIN 140 MG / 250 ml D5W IVPB; OXALIPLATIN 162 MG / 250 ML D5W IVPB; OXALIPLATIN 169 MG / 250 ML D5W IVPB; OXALIPLATIN 90 MG / 500 ML D5W IVPB; OXALIPLATIN 50 MG / 250 ML D5W IVPB; OXALIPLATIN 70 MG / 500 ML D5W IVPB; OXALIPLATIN 40 MG / 250 ML D5W IVPB; OXALIPLATIN 155 MG / 250 ML D5W IVPB; OXALIPLATIN 85 MG / 250 ML D5W IVPB OXALIPLATIN 146 MG / 250 ML D5W IVPB; OXALIPLATIN 246 MG / 500 ML D5W IVPB; OXALIPLATIN 143 MG / 250 ML D5W IVPB; OXALIPLATIN 65 MG / 500 ML D5W IVPB; OXALIPLATIN 80 MG / 500 ML D5W IVPB; OXALIPLATIN 100 MG / 250 ML D5W IVPB; OXALIPLATIN 150 MG / 250 ML D5W IVPB; OXALIPLATIN 125 MG / 250 ML D5W IVPB; OXALIPLATIN 170 MG / 250 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1797-2019

Recall number: D-1797-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 55 of 76

PACLITAXEL 258 MG / 500 ML NS IVPB; PACLITAXEL 318 MG / 500 ML NS IVPB; PACLITAXEL 385 MG / 500 ML NS IVPB; PACLITAXEL 340 MG / 500 ML NS IVPB; PACLITAXEL 332 MG / 500 ML NS IVPB; PACLITAXEL 250 MG / 500 ML NS IVPB; PACLITAXEL 117 MG / 250 ML NACL 0.9% IVPB PACLITAXEL 90 MG / 250 ML NS IVPB; PACLITAXEL 290 MG / 500 ML NS IVPB; PACLITAXEL 168 MG / 250 ML NS IVPB; PACLITAXEL 157 MG / 250 ML NS IVPB; PACLITAXEL 350 MG / 500 ML NS IVPB; PACLITAXEL 280 mg / 500 ML NS IVPB; PACLITAXEL 282 mg / 500 ML NS IVPB; PACLITAXEL 90 MG / 250 ML D5W IVPB; PACLITAXEL 255 MG / 500 ML NS IVPB; PACLITAXEL 100 MG / 250 ML NS IVPB; PACLITAXEL 80 MG / 250 ML D5W IVPB; PACLITAXEL 117 MG / 250 ML NS IVPB; PACLITAXEL 159 MG / 250 ML NS IVPB; PACLITAXEL 330 MG / 500 ML NS IVPB; PACLITAXEL135 MG / 250 ML NS IVPB; PACLITAXEL 200 MG / 500 ML NS IVPB; PACLITAXEL 150 MG / 250 ML NS IVPB; PACLITAXEL 130 MG / 250 ML NS IVPB; PACLITAXEL 144 MG / 250 ML NS IVPB; PACLITAXEL 300 MG / 500 ML NS IVPB; PACLITAXEL 120 MG / 250 ML NS IVPB; PACLITAXEL 140 MG / 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1798-2019

Recall number: D-1798-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 56 of 76

PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPB; PACLITAXEL ALBUMIN 160 MG / 100 ml NS IVPB; PACLITAXEL ALBUMIN 145 MG / 100 ml NS IVPB PACLITAXEL ALBUMIN 165 mg / 100 ml NS IVPB; PACLITAXEL ALBUMIN 150 mg /100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1799-2019

Recall number: D-1799-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 57 of 76

PACLITAXEL PROTEIN 175 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 190 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 355 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1800-2019

Recall number: D-1800-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 58 of 76

PEMBROLIZUMAB 200 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1801-2019

Recall number: D-1801-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 59 of 76

PANITUMUMAB 400 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1802-2019

Recall number: D-1802-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 60 of 76

PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB; PEMETREXED 490 MG /100 ml NS IVPB; PEMETREXED 800 mg/ 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1803-2019

Recall number: D-1803-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 61 of 76

PERJETA 420 MG/250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1804-2019

Recall number: D-1804-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 62 of 76

PERTUZUMAB 840 MG/250 ml0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1805-2019

Recall number: D-1805-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 63 of 76

PRESERVATIVE FREE 0.9% NACL 5 ML SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1806-2019

Recall number: D-1806-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 64 of 76

RAMUCIRUMAB 457 MG QS 250 ML NS IVPB; AMUCIRUMAB 1182 MG QS 250 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1807-2019

Recall number: D-1807-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 65 of 76

REMICADE 680 MG QS 250 ML 0.9% NACL IVPB; REMICADE 270 MG QS 250 ML 0.9% NACL IV; REMICADE 730 MG QS 250 ML 0.9% NACL IVPB REMICADE 330 MG QS 250 ML 0.9% NACL IVPB; REMICADE 740 MG IN 250 ML NS IVPB; REMICADE 650 MG / 250 ml 0.9% NACL; REMICADE 1200 MG/250 ml 0.9% NACL IVPB; REMICADE 800 MG/250 ml 0.9% NACL IVPB REMICADE 600 MG / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1808-2019

Recall number: D-1808-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 66 of 76

RITUXAN 728 MG QS 728 mL 0.9% NACL IVPB; RITUXAN 560 MG / 306 ml 0.9% NACL; RITUXAN 562 MG IN 562 ml 0.9% NACL; RITUXAN 700 MG QS 700 mL 0.9% NACL IVPB; RITUXAN 1000 MG / 350 mL 0.9% NACL IVPB RITUXAN 730 MG / 730 mL 0.9% NACL IVPB; RITUXAN 1000 MG QS 1000 ml NS; RITUXAN 1000 MG QS 200 ml 0.9% NACL; RITUXAN 500 MG / 300 ml 0.9% NACL; RITUXAN 660 MG QS 660 ml 0.9% NACL; RITUXAN 770 MG QS 770 mL 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1809-2019

Recall number: D-1809-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 67 of 76

RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 675 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 1000 MG / 1000 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1810-2019

Recall number: D-1810-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 68 of 76

RomiPLOStim 700 MCG/ 1.4 ML SQ SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1811-2019

Recall number: D-1811-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 69 of 76

Sodium Chloride 0.9% 1 LITER WITH Potassium Chloride 20 mEq, Mannitol 12.5 G, Magnesium Sulfate 2 G, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1812-2019

Recall number: D-1812-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 70 of 76

SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPB; SOLIRIS 900 MG QS 180 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1813-2019

Recall number: D-1813-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 71 of 76

TOPOTECAN 1.24 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1814-2019

Recall number: D-1814-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 72 of 76

TRASTUZUMAB 427 MG / 250 ml NS IVPB; TRASTUZUMAB 531 MG / 250 ML NS IVPB; TRASTUZUMAB 276 MG / 250 ML NS IVPB; TRASTUZUMAB 360 MG / 250 ML NS IVPB; TRASTUZUMAB 757 MG / 250 ML NS IVPB TRASTUZUMAB 450 MG / 250 ML NS IVPB; TRASTUZUMAB 120 MG / 250 ML NS IVPB; TRASTUZUMAB 164 MG / 250 ML NS IVPB; TRASTUZUMAB 444 MG / 250 ml NS IVPB; TRASTUZUMAB 634 MG / 250 ML NS IVPB; TRASTUZUMAB 330 MG / 250 ML NS IVPB; TRASTUZUMAB 781 MG / 250 ML NS IVPB; TRASTUZUMAB 376 mg / 250 ML NS IVPB; TRASTUZUMAB 114 MG / 250 ML NS IVPB; TRASTUZUMAB 266 MG / 250 ML NS IVPB TRASTUZUMAB 323 MG / 250 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1815-2019

Recall number: D-1815-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 73 of 76

VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE 2.2 MG/ 0.88 ML SUB-Q SYRINGE; VELCADE 2.6 MG (1.04 ML) Sub Q SYRINGE; VELCADE 4 mg / 1.6 ml SQ SYRINGE; VELCADE 2.75 mg / 1.1 ml SQ SYRINGE; VELCADE 2.6 mg / 1.04 ml SQ SYRINGE VELCADE 1.7 mg / 0.68 ml SQ SYRINGE; VELCADE 3.5 mg / 1.4 ML SQ SYRINGE; VELCADE 2.2 mg / 0.88 ml SQ SYRINGE; VELCADE 2.33 MG/ 0.93 ML SUB-Q SYRINGE; VELCADE 2.4 MG/ 0.96 ML SUB-Q SYRINGE VELCADE 2.63 MG/ 1.052 ML SUB-Q SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1816-2019

Recall number: D-1816-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 74 of 76

VINBLASTINE 10.9 MG / 100 ML D5W IVPB; VINBLASTINE 10.8 MG / 100 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1817-2019

Recall number: D-1817-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 75 of 76

VINCRISTINE 1 MG /50 ML NS IVPB; VINCRISTINE 1.2 MG /50 ML NACL 0.9% IVPB; VINCRISTINE 1 MG / 1 ML IVP SYRINGE; VINCRISTINE 2 MG /100 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1818-2019

Recall number: D-1818-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

drug · product 76 of 76

FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

D-1819-2019

Recall number: D-1819-2019
Initiated: June 12, 2019
Classification: Class II
Status: Terminated
Recalling firm: Infusion Options, Inc.
Quantity: N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

All lots within expiry

Distribution pattern

NY only

Event summary

Source snapshots represented here

Every recalled product in this event

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information